Tri Locum Partners LP: DEXCOM INC (DXCM): Quarterly 13F Position History
As of Q2 2026, Tri Locum Partners LP reported 820,479 shares of DEXCOM INC (DXCM), worth $55.3M and representing 6.8% of its 13F equity book. Quarter-over-quarter share count change: + 122,321 (+17.5%) . The position first appeared in Q2 2023 and has been disclosed across 13 13F-HR filings in Pactolio's tracked window.
- 820,479Shares Held (Latest Filing)
- $55.3MReported Market Value (Latest Filing)
- 6.8%Portfolio Weight (% of 13F Equity Book)
- +122,321Quarter-over-Quarter Share Change
- +$11.4MQuarter-over-Quarter Value Change
- 820,479Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 13 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 820,479 | +122,321 | +17.5% | $55.3M | 6.8% | $67.3 |
| Q1 2026 | 698,158 | +276,558 | +65.6% | $43.8M | 6.2% | $62.8 |
| Q4 2025 | 421,600 | +421,600 | – | $28.0M | 3.6% | $66.4 |
| Q3 2025 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2025 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2025 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2024 | 0 | 0 | – | $0 | 0.0% | – |
| Q3 2024 | 0 | 0 | – | $0 | 0.0% | – |
| Q2 2024 | 0 | 0 | – | $0 | 0.0% | – |
| Q1 2024 | 0 | 0 | – | $0 | 0.0% | – |
| Q4 2023 | 0 | 267,380 | -100.0% | $0 | 0.0% | – |
| Q3 2023 | 267,380 | +215,582 | +416.2% | $24.9M | 8.0% | $93.3 |
| Q2 2023 | 51,798 | – | – | $6.7M | 2.5% | $128.5 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Tri Locum Partners LP first disclose a DXCM position in 13F-HR filings?
Tri Locum Partners LP first reported DEXCOM INC (DXCM) on its 13F-HR filing for the period ending 2023-06-30 (Q2 2023). The position has appeared on 13 reported quarters within Pactolio's tracked window.
What was Tri Locum Partners LP's most recent quarter-over-quarter share-count change in DXCM?
Between Q1 2026 and Q2 2026, Tri Locum Partners LP added 122,321 shares of DXCM (+17.5%), bringing the total reported position to 820,479 shares at a market value of $55.3M.
Does the implied price-per-share represent Tri Locum Partners LP's cost basis in DXCM?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.